According to GuruFocus Insider Data, recent chief financial officer buys were Synalloy Corp. (SYNL, Financial), Juniper Pharmaceuticals Inc. (JNP, Financial) and NeuroMetrix Inc. (NURO, Financial).
Synalloy: Senior vice president bought 10,000 shares
Senior Vice President and CFO Dennis M. Loughran bought 10,000 shares for $7.51 per share on Sept. 6. The price of the stock has increased by 3.46%.
Synalloy has a market cap of $67.270 million. The company has a price-sales (P/S) ratio of 0.47. Synalloy's trailing 12-month dividend yield is 3.86% while the forward dividend yield is 4.20%.
Synalloy reported revenue of $34.91 million and gross profit of $4 million in the second quarter while the net loss was $1.68 million. The 2015 total revenue was $175.46 million, a 12% decrease from 2014. The 2015 gross profit was $25.32 million, a 23% decrease from 2014. The 2015 net loss was $11.52 million.
CEO and President Craig C. Bram bought 26,500 shares for $7.46 on Sept. 6. The price of the stock has increased by 4.16%.
Vice President of Corporate Administration Sarah M. Cunningham bought 4,000 shares for $7.32 per share on Sept. 7. The price of the stock has increased by 6.15%.
Director Henry L. Guy bought 20,000 shares for $7.45 per share on Sept. 6. The price of the stock has increased by 4.3%.
Juniper Pharmaceuticals: CFO bought 1,000 shares
CFO George Elston bought 1,000 shares for $5.5 per share on Aug. 31. The price of the stock has increased by 1.45%.
Juniper Pharmaceuticals has a market cap of $60.510 million. The company has a P/S ratio of 1.42.
Juniper Pharmaceuticals reported revenue of $11.88 million and gross profit of $5.42 million in the second quarter while the net loss was $1.75 million. The 2015 total revenue was $37.56 million, a 16% increase from the 2014 total revenue. The 2015 gross profit was $16.14 million, a 9% increase from the 2014 gross profit. The 2015 net loss was $2.13 million.
President and CEO Alicia Secor bought 5,000 shares for $5.75 per share on Aug. 25. The price of the stock has decreased by 2.96%.
Director C. Ann Merrifield bought 2,000 shares for $5.63 per share on Aug. 26. The price of the stock has decreased by 0.89%.
Director Frank M. Armstrong bought 1,623 shares for $6.16 per share on Aug. 23. The price of the stock has decreased by 9.42%.
NeuroMetrix: Senior vice president and CFO bought 1,400 shares
Senior Vice President and CFO Thomas T. Higgins bought 1,400 shares for $1.41 per share on Aug. 31.
Neurometrix has a market cap of $7.220 million. The company has a P/S ratio of 0.50.
NeuroMetrix reported revenue of $2.65 million and gross profit of $1.08 million in the second quarter while the net loss was $4.1 million. The 2015 total revenue was $7.3 million, a 32% increase from the 2014 total revenue. The 2015 gross profit was $3.35 million, a 14% increase from the 2014 gross profit. The 2015 net loss was $9.19 million.
President and CEO Shai Gozani bought 5,000 shares for $1.49 per share on Aug. 18. The price of the stock has decreased by 5.37%.
Disclosure:Â None.
Start a free seven-day trial of Premium Membership to GuruFocus.
